
Details
Blinatumomab Biosimilar - Research Grade
Product Details:ichorbio's blinatumomab biosimilar is for Research Use Only (RUO)
Target:CD19/CD3
Isotype:Bispecific
Other Names:MT103
Host:CHO cells
Species Reactivity:Human
Specificity:Detects human CD19/CD3.
Purification Method:This recombinant protein was purified using multi-step affinity chromatography methods such as Protein A or G depending on the species and isotype.
Background:Blinatumomab is a bispecific T-cell engager (BiTE). It enables a patient's T cells to recognize malignant B cells. A molecule of blinatumomab combines two binding sites: a CD3 site for T cells and a CD19 site for the target B cells.
Concentration:1.0 - 5.0 mg/ml
Formulation:Sterile, preservative-free, solution in PBS. BSA and Azide free.
Purity:>95% by SDS-PAGE and HPLC
Endotoxin:≤ 1.0 EU/mg as determined by the LAL method
Storage:Blinatumomab biosimilar - Research Grade is stable for at least four (4) weeks when stored sterile at 2-8°C. For long term storage aseptically aliquot in working volumes without diluting and store at –80°C. Avoid Repeated Freeze Thaw Cycles.
Applications:Functional Assays
Application Notes:Each investigator should determine their own optimal working dilution for specific applications.
Use: ichorbio's blinatumomab biosimilar is for research use only (RUO).